NewsRx

Search our medical news database

Oncology Business Week

Susan Hasty, Publisher

Table of Contents . . . December 5th, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Oncology Business Week | Other Publications

Amgen Inc. - Panitumumab with chemotherapy shows promise as colorectal cancer treatment

AstraZeneca - New data presented gefitinib's antitomor activity

Aventis - E.U. approves Taxotere (docetaxel) in prostate cancer

Celgene Corporation - FDA issues approvable letter for Thalomid sNDA

Cell Genesys, Inc. - Oncology company reports loss of $0.54 per share

CuraGen Corp. - Company details clinical development plan for CG53135 and CR002

Dendreon Corp. - Company achieves commercial scale of antigen for Provenge

Electro-Optical Sciences, Inc - Vision technology firm raises $9M, obtains protocol agreement for MelaFind

Generex Biotechnology Corporation - Melanoma vaccination results presented at conference

Genzyme Corp. - Company seeks new therapeutic indication for Thyrogen

GlaxoSmithKline - Study results show anti-tumor activity

MGI Pharma - NDA for anticancer therapeutic drug submitted to U.S. FDA by two drug companies

Matritech, Inc. - Cancer diagnostics company reports 65% increase in third quarter revenue

NeoPharm - Biopharma company presents data on NeoLipid compound, releases financial results

NeoRx Corporation - Cancer therapeutics development company reports financial results

ACLARA BioSciences - Clinical data shows eTag's potential in predicting response to cancer treatment

Amrad Corporation Limited - Cancer research deal signed for development of VEGF-B

Ariad Pharmaceuticals, Inc. - Pharmaceutical company appoints Peter J. Nelson to board

Boston Scientific Corporation - New treatment for uterine fibroids called safe and effective

Breast Cancer - Tc-99m-MIBI scintimammography inappropriate for routine evaluation of lesions

Breast Cancer Prevention - South Carolina breast cancer program should be expanded to include more women

Bristol-Myers Squibb - Trials show hepatitis B agent a statistical improvement in infected patients

British Columbia Cancer Agency - Ras oncogene uses dual modes to oppose colon cancer cell p53 expression

Center for Genetic Engineering & Biotechnology - Coadministered antigens may afford better protection against hepatitis B

Colorectal Cancer - Caffeinated coffee, but not decaf or tea, may have some protective effect

Danish Cancer Society - Preoperative plasma suPAR levels not useful as prognostic indicator

Dartmouth Medical School - HPV vaccine shown to "substantially" reduce cervical cancer

Disease Risk - Families should catalog medical history

Edinburgh University - It's time to allow people to die at home with dignity, say researchers

Endocare, Inc. - Device company inks research agreement with Columbia University Medical Center

Environmental Health - High toxic chemical levels found in Duwamish River area of Washington

Erasmus Medical Centre, Rotterdam - Basal cell carcinoma rates continuously increasing in the Netherlands since 1973

Frost & Sullivan - Study indicates new uses for therapies in treating non-small cell lung cancer

Given Imaging - Small bowel tumors study data presented at conference

I-Flow Corporation - Infusion systems developer announces 58% increase in third quarter revenues

IMPAC Medical Systems, Inc. - Oncology IT solutions company announces filing of Form 10-K/A

INSERM U396, Paris - Imatinib does not normalize blood dendritic cell levels in leukemia patients

INSERM U584, Paris - The antiangiogenic properties of 16K prolactin are still undefined in humans

INSERM, U597, Nice - PI3K mediates protection against TRAIL-induced apoptosis in melanocytes

Intercell AG - Centrosome-associated PIBF gene is overexpressed in highly proliferating cells

Johns Hopkins University - M4N induces growth arrest/apoptosis by inhibiting Cdc2 and survivin expression

Johnson & Johnson Pharmaceutical R&D, LLC - Estrogen regulates GILZ gene in cell-specific manner

Kagawa University - Motility-related protein-1 cuts off tumor metastasis by suppressing Wnt signals

Kagoshima University - Wild-type breast cancer resistance protein induces cellular resistance to NRTIs

Kansai Medical University - Total number of cancer cells reflects prognosis

Kobe University - CD25 T cell depletion and interleukin-12 gene transfer staunch melanoma growth

Lund University - Prognostic value of Ki-67 confirmed

M.D. Anderson Cancer Center - H-DNA-forming sequences cause mammalian cell mutations

M.D. Anderson Cancer Center - Neural SC REST/NRSF gene activation sufficient to cause neuronal differentiation

Marshall Edwards, Inc. - U.S. FDA fast-tracks phenoxodiol for recurrent ovarian cancer

Massey University - Childhood obesity increases later cancer risk, especially for smokers

Maxim Pharmaceuticals - Negative outcome on malignant melanoma trial reported

Mayo Clinic - Transforming growth factor regulates angiogenic factors in pituitary cells

MediGene AG - License agreement for cancer-killing herpes virus concluded

Meditech Research Limited - Colon cancer trial information presented at conference

National Taiwan University Hospital - Adenovirus vectors that express Fas ligand may treat allergic asthma

National Taiwan University Hospital - Allelic loss on chromosome 4q is linked to hepatitis B-related liver cancer

Natl. Autonomous Univ. of Mexico - Two pathways can activate IL-2 receptor signaling in HPV-associated cancer

Natl. Inst. of Radiologic Science, Japan - Lonidamine plus radiation increase melanoma cell apoptosis

Northwestern University - Researchers investigate effect of tomato oil on precancerous prostate changes

Oakland University - Edpm5 guides the control of angiogenesis in rodent pituitary tumors

Ohio State University - Role of cancer-associated stromal fibroblasts in liver metastasis determined

Oncolytics Biotech Inc. - Biotech company announces issuance of reovirus patent

Onyx Pharmaceuticals, Inc. - Pharma company reports third quarter and 9 month 2004 financial results

Osaka National Hospital - Virological responders to hepatitis therapy retain mild liver inflammation

Osaka University - IL-6 regulates dendritic cell differentiation through STAT3 activation

Osaka University - Microbubble-enhanced ultrasound augments central nerve system transfection

Peking University - Genes with unique expression in liver cancers may be drug targets

Pharmacopeia Drug Discovery, Inc. - Drug discovery company announces third quarter 2004 results

Pharmacyclics, Inc. - Pharma company presents data on Xcytrin Injection trial

Professor Alexander Posadas National Hospital - Obesity delineates nonalcoholic steatohepatitis fibrosis progression

Progenics Pharmaceuticals - Pharma companies awarded NIH grants for prostate cancer immunotherapies

R2 Technology, Inc. - Computer-aided detection technology company appoints chief financial officer

RITA Medical Systems, Inc. - Medical oncology device company announces third quarter, 9-month results

RITA Medical Systems, Inc. - Pilot study examines new radiofrequency ablation-assisted lumpectomy

Rejuvenon Corporation - Pharma company appoints president and CEO

Roche Oncology - Oral targeted colon cancer drug shown to improve outcomes, cut post-op costs

Roswell Park Cancer Institute - Polystyrene bead system useful in CTL activity analysis

Russells Hall Hospital, U.K. - Intra-operative specimen radiographs help minimize necessary tissue excision

Sapporo Medical University - Suppressed E1AF limits the invasiveness of cervical cancer

Schering-Plough Corporation - FDA grants priority review status for brain tumor drug; EMEA application made

Seoul National University - Mature yuzu could be a significant dietary source of antioxidants

Signet Laboratories - Lab announces availability of monoclonal antibody for detecting prostate cancer

Smoking Ban - Second Nevada petition would restrict smoking in public

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook